Diagnostic Test Portfolio

Protagen is developing generic & proprietary tests to enable physicians to accurately diagnose patients who have critical autoimmune diseases, such as RA, SLE, SSc and others, earlier in the disease progression, which will enable earlier treatment and improve long-term outcomes. We are also developing tests to enable patient stratification, prognosis and disease-modified therapy response prediction, all with the goal of improving individualized patient care.

Multilisa SSc

Discover our pipeline of novel diagnostic tests from discovery and development to market-ready, CE-approved products across a range of autoimmune indications with unmet diagnostic and therapeutic needs.

Multilisa SLE

The Multilisa SLE® provides a more accurate diagnosis by utilizing new and established auto-antigens to create more highly sensitive and specific tests compared to currently marketed products.